Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Protagonist Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Protagonist Therapeutics Inc
Rating: 1.93941675
Author: Trendlyne DVM scores

about

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology,...

103.78 0.11 (0.11%)

New 52W High in past week

601.6K

XNAS Volume

XNAS 02 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.7 / 100

Technically Bullish

72.9 / 100

112

1Yr Price target upside is 8%

12 analysts

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology,...

New 52W High in past week

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart